UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.299-302

2005

Volltextzugriff (PDF)

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

Annals of the rheumatic diseases, 2005-08, Vol.64 (8), p.1145-1149

2005

Volltextzugriff (PDF)

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1587-1593

2004

Volltextzugriff (PDF)

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Annals of the rheumatic diseases, 2004-09, Vol.63 (9), p.1155-1158

2004

Volltextzugriff (PDF)

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

Annals of the rheumatic diseases, 2000-12, Vol.59 (12), p.945-953

2000

Volltextzugriff (PDF)

Characterisation of human knee meniscus cell phenotype

Osteoarthritis and cartilage, 2005-07, Vol.13 (7), p.548-560

2005

Volltextzugriff (PDF)

Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

Annals of the rheumatic diseases, 2002-03, Vol.61 (3), p.207-212

2002

Volltextzugriff (PDF)

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease

Annals of the rheumatic diseases, 2005-06, Vol.64 (6), p.930-935

2005

Volltextzugriff (PDF)

Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.321-324

2005

Volltextzugriff (PDF)

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.829-834

2003

Volltextzugriff (PDF)

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy

Annals of the rheumatic diseases, 2003-05, Vol.62 (5), p.455-459

2003

Volltextzugriff (PDF)

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

Annals of the rheumatic diseases, 2001-12, Vol.60 (12), p.1131-1136

2001

Volltextzugriff (PDF)

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

Annals of the rheumatic diseases, 2001-08, Vol.60 (8), p.750-755

2001

Volltextzugriff (PDF)

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1542-1549

2005

Volltextzugriff (PDF)

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy

Annals of the rheumatic diseases, 2005-04, Vol.64 (4), p.529-536

2005

Volltextzugriff (PDF)

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association

Journal of rheumatology, 2000-12, Vol.27 (12), p.2860

2000

Volltextzugriff (PDF)

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

British journal of rheumatology, 2005-04, Vol.44 (4), p.465-468

2005

Volltextzugriff (PDF)

Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs

Clinical rheumatology, 2002-06, Vol.21 (3), p.231-243

2002

Volltextzugriff (PDF)

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.929-933

2002

Volltextzugriff (PDF)

Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1316-1320

2005

Volltextzugriff (PDF)

Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.1022-1029

2009

Volltextzugriff (PDF)

Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks

Annals of the rheumatic diseases, 2001-08, Vol.60 (8), p.781-790

2001

Volltextzugriff (PDF)

Ankylosing spondylitis : what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial

British journal of rheumatology, 1999-03, Vol.38 (3), p.235-244

1999

Volltextzugriff (PDF)

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

Annals of the rheumatic diseases, 2002-12, Vol.61 (12), p.1090-1094

2002

Volltextzugriff (PDF)

The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications

Lupus, 2005-01, Vol.14 (12), p.931-937

2005

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(450)
Mit Volltextzugriff
(368)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(389)
Science & Technology
(328)
Life Sciences & Biomedicine
(326)
Male
(223)
Female
(216)
Rheumatology
(197)
Adult
(177)
Biological And Medical Sciences
(176)
Middle Aged
(171)
Medical Sciences
(166)
Aged
(125)
Adolescent
(92)
Diseases Of The Osteoarticular System
(85)
Inflammatory Joint Diseases
(70)
Child
(64)
Arthritis, Rheumatoid - Immunology
(54)
Arthritis, Rheumatoid - Drug Therapy
(44)
Hematology
(43)
Child, Preschool
(42)
Immunology
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Rheumatology
(62)
Annals Of The Rheumatic Diseases
(61)
Clinical And Experimental Rheumatology
(34)
Arthritis And Rheumatism
(28)
The Lancet
(20)
Clinical Rheumatology
(18)
Arthritis Research & Therapy
(17)
Blood
(17)
Osteoarthritis And Cartilage
(12)
Bone Marrow Transplantation
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

Characterisation of human knee meniscus cell phenotype

Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease

Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy

Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs

Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease

Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies

Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade

Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks

Ankylosing spondylitis : what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial

Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype

The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications

Suchergebnisse filtern